Article thumbnail
Location of Repository

Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma

By Yasuhiro Matsuo and Tetsu Kamitani
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2864738
Provided by: PubMed Central

Suggested articles

Citations

  1. (2002). A role for alphasynuclein in the regulation of dopamine biosynthesis.
  2. (2005). Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.
  3. (2009). Ascherio A
  4. (2005). Atypical cancer pattern in patients with Parkinson’s disease.
  5. (1998). Comparative analysis of the in vivo expression of tyrosinase, MART-1/MelanA, and gp100 in metastatic melanoma lesions: implications for immunotherapy.
  6. (2005). Cutaneous melanoma.
  7. (1999). Detection of microscopic melanoma metastases in sentinel lymph nodes.
  8. (2001). Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.
  9. (2009). Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology.
  10. (2006). Malignant melanoma and other types of cancer preceding Parkinson disease.
  11. (2009). Melanoma biomarkers: current status and vision for the future.
  12. (1999). Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
  13. (2007). Melanosomes–dark organelles enlighten endosomal membrane transport.
  14. (2009). Molecular mechanisms of alpha-synuclein neurodegeneration.
  15. (2007). Oculocutaneous albinism. Orphanet J Rare Dis 2: 43. a-Synuclein in
  16. (2002). Specification of catecholaminergic and serotonergic neurons.
  17. (2002). The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins.
  18. (2001). The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (antimelan-A).

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.